An open-label study to evaluate the inflammatory markers in adult patients with asthma associated with allergic rhinitis receiving montelukast therapy.

Trial Profile

An open-label study to evaluate the inflammatory markers in adult patients with asthma associated with allergic rhinitis receiving montelukast therapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Sep 2017

At a glance

  • Drugs Montelukast (Primary)
  • Indications Allergic rhinitis; Asthma
  • Focus Biomarker; Pharmacodynamics
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 01 Feb 2007 Status changed from recruiting.
    • 12 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top